The glial cell modulators, ibudilast and its amino analog, AV1013, attenuate methamphetamine locomotor activity and its sensitization in mice

European Journal of Pharmacology

Volumn 679, Issue 1-3, 2012, Pages 75-80

  Snider, Sarah E ^a   Vunck, Sarah A ^a   Van Den Oord, Edwin J C G ^a   Adkins, Daniel E ^a   McClay, Joseph L ^a   Beardsley, Patrick M ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

Author keywords

AV1013; AV411; Glial; Ibudilast; Locomotor activity; Methamphetamine; Relapse; Sensitization

Indexed keywords

2 AMINO 1 (2 ISOPROPYLPYRAZOLO [1,5 A]PYRIDINE 3 YL)PROPAN 1 ONE; AV 1013; IBUDILAST; METHAMPHETAMINE; PHOSPHODIESTERASE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL ACTIVATION; CELL ACTIVITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; DOSE RESPONSE; DRUG ACTIVITY; DRUG MECHANISM; DRUG SENSITIZATION; ENZYME INHIBITION; GLIA CELL; HYPERACTIVITY; LOCOMOTION; MALE; MOUSE; NEUROMODULATION; NEUROTRANSMISSION; NONHUMAN; PRIORITY JOURNAL; RELAPSE;

ANIMALS; CENTRAL NERVOUS SYSTEM SENSITIZATION; CENTRAL NERVOUS SYSTEM STIMULANTS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; MALE; METHAMPHETAMINE; MICE; MICE, INBRED C57BL; MOTOR ACTIVITY; PHOSPHODIESTERASE INHIBITORS; PYRIDINES;

EID: 84857785244     PISSN: 00142999     EISSN: 18790712     Source Type: Journal    
DOI: 10.1016/j.ejphar.2012.01.013     Document Type: Article

References (55)

1. P. Beardsley, K. Shelton, E. Hendrick, and K. Johnson The glial cell modulator and phosphodiesterase inhibitor, AV411 (ibudilast), attenuates prime- and stress-induced methamphetamine relapse Eur. J. Pharmacol. 637 2010 102 108
2. E.C. Beattie, D. Stellwagen, W. Morishita, J.C. Bresnahan, B.K. Ha, M. Von Zastrow, M.S. Beattie, and R.C. Malenka Control of synaptic strength by glial TNFalpha Science 295 2002 2282 2285 (Pubitemid 34258846)
3. J.A. Beavo Cyclic nucleotide phosphodiesterases: functional implications of multiple isoforms Physiol. Rev. 75 1995 725 748
4. G.E. Bigelow, R.R. Griffiths, and I.A. Liebson Pharmacological influences upon human ethanol self-administration Adv. Exp. Med. Biol. 85B 1977 523 538
5. G.L. Caporaso, J.A. Bibb, G.L. Snyder, C. Valle, S. Rakhilin, A.A. Fienberg, H.C. Hemmings, A.C. Nairn, and P. Greengard Drugs of abuse modulate the phosphorylation of ARPP-21, a cyclic AMP-regulated phosphoprotein enriched in the basal ganglia Neuropharmacology 39 2000 1637 1644 (Pubitemid 30330880)
6. J.C. Chen, P.C. Chen, and Y.C. Chiang Molecular mechanisms of psychostimulant addiction Chang Gung Med. J. 32 2009 148 154
7. A.K. Cho, and D.S. Segal Amphetamine and its Analogs: Psychopharmacology, Toxicology, and Abuse 1994 Academic Press San Diego
8. Y. Cho, G. Crichlow, J. Vermeire, L. Leng, X. Du, M. Hodsdon, R. Bucala, M. Cappello, M. Gross, F. Gaeta, K. Johnson, and E. Lolis Allosteric inhibition of macrophage migration inhibitory factor revealed by ibudilast Proc. Natl. Acad. Sci. U. S. A. 107 2010 11313 11318
9. W.M. Chornock, M.L. Stitzer, J. Gross, and S. Leischow Experimental model of smoking re-exposure: effects on relapse Psychopharmacology (Berl) 108 1992 495 500
10. I. Creese Stimulants, Neurochemical, Behavioral, and Clinical Perspectives 1983 Raven Press New York
11. H. de Wit Priming effects with drugs and other reinforcers Exp. Clin. Psychopharmacol. 4 1996 5 10 (Pubitemid 26077288)
12. C. Eroglu, and B.A. Barres Regulation of synaptic connectivity by glia Nature 468 2010 223 231
13. B.J. Everitt, and T.W. Robbins Neural systems of reinforcement for drug addiction: from actions to habits to compulsion Nat. Neurosci. 8 2005 1481 1489 (Pubitemid 41573659)
14. L.C. Gibson, S.F. Hastings, I. McPhee, R.A. Clayton, C.E. Darroch, A. Mackenzie, F.L. Mackenzie, M. Nagasawa, P.A. Stevens, and S.J. Mackenzie The inhibitory profile of Ibudilast against the human phosphodiesterase enzyme family Eur. J. Pharmacol. 538 2006 39 42 (Pubitemid 44255726)
15. J. Goncalves, T. Martins, R. Ferreira, N. Milhazes, F. Borges, C.F. Ribeiro, J.O. Malva, T.R. Macedo, and A.P. Silva Methamphetamine-induced early increase of IL-6 and TNF-alpha mRNA expression in the mouse brain Ann. N. Y. Acad. Sci. 1139 2008 103 111
16. J. Goncalves, S. Baptista, T. Martins, N. Milhazes, F. Borges, C.F. Ribeiro, J.O. Malva, and A.P. Silva Methamphetamine-induced neuroinflammation and neuronal dysfunction in the mice hippocampus: preventive effect of indomethacin Eur. J. Neurosci. 31 2010 315 326
17. D.T. Hamamoto, and N.L. Rhodus Methamphetamine abuse and dentistry Oral Dis. 15 2009 27 37
18. P. Hauer Systemic affects of methamphetamine use S. D. Med. 63 2010 285 287
19. M.A. Hebert, and J.P. O'Callaghan Protein phosphorylation cascades associated with methamphetamine-induced glial activation Ann. N. Y. Acad. Sci. 914 2000 238 262
20. M. Hutchinson, S. Lewis, B. Coats, D. Skyba, N. Crysdale, D. Berkelhammer, A. Brzeski, A. Northcutt, C. Vietz, C. Judd, S. Maier, L. Watkins, and K. Johnson Reduction of opioid withdrawal and potentiation of acute opioid analgesia by systemic AV411 (ibudilast) Brain Behav. Immun. 23 2009 240 250
21. M. Iyo, Y. Maeda, T. Inada, Y. Kitao, H. Sasaki, and S. Fukui The effects of a selective cAMP phosphodiesterase inhibitor, rolipram, on methamphetamine-induced behavior Neuropsychopharmacology 13 1995 33 39
22. M. Iyo, Y. Bi, K. Hashimoto, T. Inada, and S. Fukui Prevention of methamphetamine-induced behavioral sensitization in rats by a cyclic AMP phosphodiesterase inhibitor, rolipram Eur. J. Pharmacol. 312 1996 163 170 (Pubitemid 26325675)
23. M. Iyo, Y. Bi, K. Hashimoto, S. Tomitaka, T. Inada, and S. Fukui Does an increase of cyclic AMP prevent methamphetamine-induced behavioral sensitization in rats? Ann. N. Y. Acad. Sci. 801 1996 377 383 (Pubitemid 27029025)
24. L. Karila, A. Weinstein, H.J. Aubin, A. Benyamina, M. Reynaud, and S.L. Batki Pharmacological approaches to methamphetamine dependence: a focused review Br. J. Clin. Pharmacol. 69 2010 578 592
25. R.E. Kast Tumor necrosis factor has positive and negative self regulatory feed back cycles centered around cAMP Int. J. Immunopharmacol. 22 2000 1001 1006
26. J.W. Kebabian, M. Beaulieu, and Y. Itoh Pharmacological and biochemical evidence for the existence of two categories of dopamine receptor Can. J. Neurol. Sci. 11 1984 114 117 (Pubitemid 14133452)
27. M.A. Kelly, M.J. Low, M. Rubinstein, and T.J. Phillips Role of dopamine D1-like receptors in methamphetamine locomotor responses of D2 receptor knockout mice Genes Brain Behav. 7 2008 568 577 (Pubitemid 351991491)
28. Y. Kishi, S. Ohta, N. Kasuya, S. Sakita, T. Ashikaga, and M. Isobe Ibudilast: a non-selective PDE inhibitor with multiple actions on blood cells and the vascular wall Cardiovasc. Drug Rev. 19 2001 215 225 (Pubitemid 34019905)
29. A. Ledeboer, T. Liu, J.A. Shumilla, J.H. Mahoney, S. Vijay, M.I. Gross, J.A. Vargas, L. Sultzbaugh, M.D. Claypool, L.M. Sanftner, L.R. Watkins, and K.W. Johnson The glial modulatory drug AV411 attenuates mechanical allodynia in rat models of neuropathic pain Neuron Glia Biol. 2 2006 279 291 (Pubitemid 47074741)
30. T.O. Lilius, P.V. Rauhala, O. Kambur, and E.A. Kalso Modulation of morphine-induced antinociception in acute and chronic opioid treatment by ibudilast Anesthesiology 111 2009 1356 1364
31. J.M. Loftis, D. Choi, W. Hoffman, and M.S. Huckans Methamphetamine causes persistent immune dysregulation: a cross-species, translational report Neurotox. Res. 20 2010 59 68
32. J.J. Miguel-Hidalgo The role of glial cells in drug abuse Curr. Drug Abuse Rev. 2 2009 76 82
33. T. Mizuno, T. Kurotani, Y. Komatsu, J. Kawanokuchi, H. Kato, N. Mitsuma, and A. Suzumura Neuroprotective role of phosphodiesterase inhibitor ibudilast on neuronal cell death induced by activated microglia Neuropharmacology 46 2004 404 411 (Pubitemid 38223874)
34. T. Mori, J. Baba, Y. Ichimaru, and T. Suzuki Effects of rolipram, a selective inhibitor of phosphodiesterase 4, on hyperlocomotion induced by several abused drugs in mice Jpn. J. Pharmacol. 83 2000 113 118 (Pubitemid 30449739)
35. A. Nakajima, K. Yamada, T. Nagai, T. Uchiyama, Y. Miyamoto, T. Mamiya, J. He, A. Nitta, M. Mizuno, M.H. Tran, A. Seto, M. Yoshimura, K. Kitaichi, T. Hasegawa, K. Saito, Y. Yamada, M. Seishima, K. Sekikawa, H.C. Kim, and T. Nabeshima Role of tumor necrosis factor-alpha in methamphetamine-induced drug dependence and neurotoxicity J. Neurosci. 24 2004 2212 2225 (Pubitemid 38314553)
36. M. Niwa, A. Nitta, K. Yamada, and T. Nabeshima The roles of glial cell line-derived neurotrophic factor, tumor necrosis factor-alpha, and an inducer of these factors in drug dependence J. Pharmacol. Sci. 104 2007 116 121 (Pubitemid 46974984)
37. M. Niwa, Y. Yan, and T. Nabeshima Genes and molecules that can potentiate or attenuate psychostimulant dependence: relevance of data from animal models to human addiction Ann. N. Y. Acad. Sci. 1141 2008 76 95
38. E. Peachey, B. Rogers, J.F. Brien, A. Maclean, and D. Rogers Measurement of acute and chronic behavioural effects of methamphetamine in the mouse Psychopharmacology (Berl) 48 1976 271 275
39. T.E. Robinson, and K.C. Berridge The neural basis of drug craving: an incentive-sensitization theory of addiction Brain Res. Rev. 18 1993 247 291 (Pubitemid 23219500)
40. K.W. Sax, and S.M. Strakowski Behavioral sensitization in humans J. Addict. Dis. 20 2001 55 65 (Pubitemid 33095758)
41. B.D. Shames, R.C. McIntyre Jr., D.D. Bensard, E.J. Pulido, C.H. Selzman, L.L. Reznikov, A.H. Harken, and X. Meng Suppression of tumor necrosis factor alpha production by cAMP in human monocytes: dissociation with mRNA level and independent of interleukin-10 J. Surg. Res. 99 2001 187 193 (Pubitemid 32703436)
42. P.K. Sonsalla, J.W. Gibb, and G.R. Hanson Roles of D1 and D2 dopamine receptor subtypes in mediating the methamphetamine-induced changes in monoamine systems J. Pharmacol. Exp. Ther. 238 1986 932 937 (Pubitemid 16033231)
43. M. Srisurapanont, R. Ali, J. Marsden, A. Sunga, K. Wada, and M. Monteiro Psychotic symptoms in methamphetamine psychotic in-patients Int. J. Neuropsychopharmacol. 6 2003 347 352 (Pubitemid 38146252)
44. J.D. Steketee, and P.W. Kalivas Drug wanting: behavioral sensitization and relapse to drug-seeking behavior Pharmacol. Rev. 63 2011 348 365
45. D. Stellwagen, and R.C. Malenka Synaptic scaling mediated by glial TNF-alpha Nature 440 2006 1054 1059
46. S.M. Strakowski, and K.W. Sax Progressive behavioral response to repeated d-amphetamine challenge: further evidence for sensitization in humans Biol. Psychiatry. 44 1998 1171 1177 (Pubitemid 28547152)
47. A. Suzumura, A. Ito, M. Yoshikawa, and M. Sawada Ibudilast suppresses TNFalpha production by glial cells functioning mainly as type III phosphodiesterase inhibitor in the CNS Brain Res. 837 1999 203 212 (Pubitemid 29369233)
48. L.J. Vanderschuren, and B.J. Everitt Behavioral and neural mechanisms of compulsive drug seeking Eur. J. Pharmacol. 526 2005 77 88 (Pubitemid 41744107)
49. B.T. Winslow, K.I. Voorhees, and K.A. Pehl Methamphetamine abuse Am. Fam. Physician 76 2007 1169 1174
50. M.E. Wolf The role of excitatory amino acids in behavioral sensitization to psychomotor stimulants Prog. Neurobiol. 54 1998 679 720 (Pubitemid 28137703)
51. T. Yamaguchi, Y. Kuraishi, M. Minami, S. Nakai, Y. Hirai, and M. Satoh Methamphetamine-induced expression of interleukin-1 beta mRNA in the rat hypothalamus Neurosci. Lett. 128 1991 90 92
52. Y. Yan, T. Mizuno, A. Nitta, K. Yamada, and T. Nabeshima Nefiracetam attenuates methamphetamine-induced discriminative stimulus effects in rats Ann. N. Y. Acad. Sci. 1025 2004 274 278 (Pubitemid 39643872)
53. Y. Yan, A. Nitta, T. Mizuno, A. Nakajima, K. Yamada, and T. Nabeshima Discriminative-stimulus effects of methamphetamine and morphine in rats are attenuated by cAMP-related compounds Behav. Brain Res. 173 2006 39 46 (Pubitemid 44572014)
54. Y. Yan, K. Yamada, M. Niwa, T. Nagai, A. Nitta, and T. Nabeshima Enduring vulnerability to reinstatement of methamphetamine-seeking behavior in glial-cell-line-derived neurotrophic factor mutant mice FASEB J. 21 2007 1994 2004 (Pubitemid 47026435)
55. L. Zhang, K. Kitaichi, Y. Fujimoto, H. Nakayama, E. Shimizu, M. Iyo, and K. Hashimoto Protective effects of minocycline on behavioral changes and neurotoxicity in mice after administration of methamphetamine Prog. Neuropsychopharmacol. Biol. Psychiatry 30 2006 1381 1393 (Pubitemid 44634942)